跳转至内容
Merck
  • The mechanical environment in Dupuytren's contracture determines cell contractility and associated MMP-mediated matrix remodeling.

The mechanical environment in Dupuytren's contracture determines cell contractility and associated MMP-mediated matrix remodeling.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society (2012-09-19)
Jennifer S N Verhoekx, Kate S Beckett, Marcus A Bisson, Duncan A McGrouther, Adriaan O Grobbelaar, Vivek Mudera
摘要

Matrix metalloproteinases (MMPs) are expressed in Dupuytren's contracture and play a role in matrix remodeling. We tested the role of tension on contractility and MMP expression in Dupuytren's nodule and cord cells. Cells were subjected to pre-determined loading patterns of known repeatable magnitudes (static load, unloading, and overloading) and tested for MMP gene expression (MMP-1, -2, -9, -13, and TIMP-1, -2) and force generation using a tension-culture force monitor. Matrix remodeling was assessed by addition of cytochalasin D and residual matrix tension was quantified. Nodule compared to cord and control cells demonstrate greater force generation and remodeling (p < 0.05). Nodule cells subjected to a reduced load and overloading led to threefold increase of MMP-1, -2, and -9 compared to static load, whilst cord and control cells only showed a twofold increase of MMP-9. Nodule cells subjected to overloading showed a twofold increase in TIMP-2 expression, whilst cord and control cells showed a twofold increase in TIMP-1 expression. Nodule cells differ from cord cells by increased force generation in response to changes in the mechanical environment and related MMP/TIMP-mediated matrix remodeling. In turn this may lead to permanent matrix shortening and digital contracture. Interventional therapies should be aimed at nodule cells to prevent contraction and subsequent permanent matrix remodeling.

材料
货号
品牌
产品描述

Sigma-Aldrich
细胞松驰素D, from Zygosporium mansonii, ≥98% (TLC and HPLC), powder
Sigma-Aldrich
细胞松驰素D, Ready Made Solution, from Zygosporium mansonii, 5 mg/mL in DMSO